Kura Oncology, Inc. (KURA) Q1 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Please stand by, your program is about to begin. If you need assistance during your conference today, please press star zero. Good day, everyone, and welcome to today's first quarter 2025 Cura Oncology Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later, you will have the opportunity to ask questions during the question and answer session. You may register to ask a question at any time by pressing star one on your telephone keypad. You may withdraw yourself from the queue by pressing star two. Please note this call may be recorded and I will be standing by if you should need any assistance. It is now my pleasure to turn the conference over to Apoorva Chollui. Please go ahead. Thank you, operator. Good afternoon and welcome to Cura Oncology's first quarter 2025 conference call. Joining me on the call are Dr. Troy Wilson, President and Chief Executive Officer, Dr. Molly Leone, Chief Medical Officer, Brian Powell, Chief Commercial Officer, and Tom Doyle, Senior Vice President of Finance and Accounting. Before I turn the call over to Dr. Wilson, I'd like to remind you that today's call will include forward-looking statements based on current expectations. Such statements represent management's judgment as of today and may involve risks and uncertainties that could cause actual results to differ materially from expected results. Please refer to Cura's filings with the SEC which are available from the SEC or on the Cora Oncology website for information concerning risk factors that could affect the company. With that, I'll turn the call over to Troy. Thank you, Apoorva. Good afternoon, and thank you all for joining us. Over the past quarter, we've made substantial progress executing against our pipeline. We've achieved importan...